Viyash Scientific · NSE: VIYASH · BSE: 512529
Q2 FY21 results · Jul–Sep 2020
Viyash Scientific reported revenue from operations of ₹346.27 crore (up 21.8% from Q2 FY20) and net profit of ₹21.36 crore (down 12.7% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 346.27 | 284.22 | +21.8% | 310.26 | +11.6% |
| Other income | 2.63 | 5.97 | −55.9% | 1.55 | +70.3% |
| Total income | 348.91 | 290.19 | +20.2% | 311.81 | +11.9% |
| Profit before tax | 29.32 | 22.83 | +28.5% | 31.89 | −8.0% |
| Net profit for the period | 21.36 | 24.47 | −12.7% | 24.47 | −12.7% |
| Attributable to shareholders of the company | 21.26 | 21.29 | −0.1% | 20.92 | +1.6% |
| EPS, basic (₹) | 0.86 | 0.88 | −2.3% | 0.85 | +1.2% |
| Net margin (%) | 6.2 | 8.6 | 7.9 |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 69.64 | 51.52 | +35.2% | 59.24 | +17.5% |
| Other income | 6.10 | 7.20 | −15.2% | 2.27 | +168.2% |
| Total income | 75.74 | 58.72 | +29.0% | 61.52 | +23.1% |
| Profit before tax | 11.03 | 6.64 | +66.1% | 8.80 | +25.4% |
| Net profit for the period | 9.21 | 10.18 | −9.5% | 6.91 | +33.3% |
| EPS, basic (₹) | 0.37 | 0.42 | −11.9% | 0.28 | +32.1% |
| Net margin (%) | 13.2 | 19.8 | 11.7 |
Consolidated
- Filed with BSE
- 09 Nov 2020, 19:19 IST
- Board meeting
- 06 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2020, 19:19 IST
- Board meeting
- 06 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE